AIDS WEEKLY Plus - May 2001Important note: Information in this article was accurate in May 2001. The state of the art may have changed since the publication date.
Click here to return to AIDS WEEKLY PLUS main menu

Disease Progression: Overweight May Slow Onset Of Full-Blown AIDS

AIDSWEEKLY Plus; Monday, May 14, 2001
Michael Greer, Staff Medical Writer


NewsRx - Gaining a few extra pounds may help prevent the progression of HIV to full-blown AIDS, although the reasons are still unclear.

J. Shuter and colleagues at Montefiore Medical Center in the Bronx conducted a study to "determine the prevalence and predictive value of overweight in an urban HIV clinic." The results were published in the Journal of Acquired Immune Deficiency Syndromes.

Surprisingly, they found that patients who were overweight tended to have lower viral loads and were less likely to progress to AIDS than patients with a lower body mass index (BMI).

Female patients were much more likely to be overweight than male patients, Shuter et al. said. Almost a third (32.5%) of HIV positive women were overweight at the beginning of the study, and more than half became overweight at some point before its conclusion.

Overweight patients had immune cell counts similar to those of their lighter counterparts, and they began therapy at roughly the same time. Still, these patients displayed a trend toward reduced plasma HIV RNA levels and delayed progression to AIDS, study data showed.

A low BMI at baseline was strongly linked to AIDS progression, as was subsequent weight reduction ("Prevalence and predictive value of overweight in an urban HIV care clinic," J Acquir Immune Defic Syndr 2001 Mar 1;26(3):291-7.

"Overweight was a common and underrecognized finding, particularly among women," Shuter and colleagues concluded. "Overweight patients may progress more slowly to AIDS than non-overweight patients."

The corresponding author for this report is J. Shuter, Montefiore Medical Center, AIDS Center, Dept. of Medicine, Division of Infectious Diseases, Gold Zone1st Floor, 111 East 210th St., Bronx, NY 10467 USA.

Key points reported in this study include:

This article was prepared by AIDS Weekly editors from staff and other reports.

010514
AW010506


Copyright © 2001 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsrx.net

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1990,2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.